Table 2.
Parameter | Group A n = 31 (Peg-IFNα + RBV + placebo) |
Group B n = 31 (Peg-IFNα + RBV + Silybin, Vit E, phospholipids) |
p-value |
---|---|---|---|
Mean age (years) | 45.8 ± 3.9 | 47.2 ± 3.7 | N.S. |
HCV exposure time (years) | 5.87 ± 4.9 | 5.96 ± 4.2 | N.S |
BMI (kg/m2) | 27.8 ± 3.1 | 27.4 ± 3.6 | N.S. |
Plasma glucose (mmol/l) (normal 3.9–6.4) | 5.6 ± 0.78 | 5.9 ± 0.70 | N.S. |
AST (IU/l) (normal 15–50) | 173.2 ± 37.8 | 178.4 ± 37.4 | N.S. |
ALT (IU/l) (normal 15–50) | 187.2 ± 37.2 | 184.1 ± 38.2 | N.S. |
Viremia (106 IU/ml) | 5.21 ± 2.24 | 5.20 ± 2.44 | N.S. |
HAI | 10.7 ± 3.2 | 10.9 ± 3.4 | N.S. |